Latent TB Detection Market: Government Initiatives to Promote Tuberculosis Detection
According to our new market research study on “Latent TB Detection Market to 2027 – COVID-19 Impact and Global Analysis – by Test and End User,” the market is expected to reach US$ 1,684.86 million in 2027 from US$ 1,131.82 million in 2019. The market is estimated to grow with a CAGR of 5.2% from 2020-2027. The growth of the market is attributed to the increasing prevalence of tuberculosis and government initiatives to promote tuberculosis detection. However, multidrug resistant tuberculosis (MDR-TB) is likely to hamper the growth of the market to a certain extent.
Tuberculosis (TB) can stay dormant for years before developing into an active TB disease. This condition is known as latent TB. Diagnosis of latent TB is imperative, as it will develop into infectious TB disease when the immune system becomes weak. The World Health Organization (WHO) stated that a total of 1.4 million people died from TB in 2019, making TB one of the top 10 causes of mortality in the world. The data also stated that in 2019 TB affected 10 million people in the world, of which 56% were adult males, 32% were adult females, and 12% were children. The disease is prevalent in all age groups worldwide. Furthermore, according to the Global Health Education (GHE), a UK-based registered charity, the high TB burden countries accounted for 86% of the estimated cases worldwide. India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa are among the countries that are highly affected with TB. Therefore, the high prevalence of TB is driving the need for TB tests, in turn, propelling the growth of the latent TD detection market.
Request for sample Report at: https://www.theinsightpartners.com/sample/TIPRE00014239/
Key Findings from The Latent TB Detection Market
- Based on test, the latent TB detection market was segmented into Tuberculin Skin Test (TST) and Interferon Gamma Released Assay (IGRA). In 2019, the Interferon Gamma Released Assay (IGRA) segment accounted for the highest share in the market and is likely to retain its dominant share.
- Also, the similar segment is expected to witness fastest growth in the market owing to the accuracy obtained through these tests. The IGRA test has numerous advantages over the TST of not needing the patient to return for test result evaluation. Current IGRAs do not cross-react with most non-TB mycobacteria, including Bacille Calmette-Guerin (BCG) strains.
- Based on end user, the latent TB detection market is segmented into hospitals, diagnostic centers, laboratory and others. The hospitals segment held the largest share of the market in 2019. Moreover, the same segment is estimated to register the highest CAGR in the market during the forecast period.
- The latent TB detection market players such as QIAGEN, BioMeriux S.A., F. Hoffmann La-Roche Ltd., BD, ARKRAY, Inc., Abbott, Serum Institute of India Pvt. Ltd, Oxford Immunotec Ltd, Lionex GmbH have been adopting several organic and inorganic strategies to enhance their revenue and market standings. For instance, in September 2020, Oxford Immunotec received approval from the FDA to allow use of the T-SPOT.TB test in two years of age and older. This will help in meeting the pediatric patients needs for TB management.
Government Initiatives to Promote Tuberculosis Detection
The disease disproportionally affects the poor, vulnerable, undernourished, and marginalized people worldwide. Evidence from various sources such as World Health Organization (WHO) and the United Nations (UN) shows that countries such as India and Indonesia in Asia Pacific are highly populated with patients suffering from TB. Thus, the government bodies in these countries are undertaking and adopting certain schemes and initiatives in containing the disease. For instance, the Indian National Strategic Plan (NSP) that aims for TB elimination has been established from 2017 to 2025; it institutes several patient support groups and protection measures along with the provision of free TB diagnostic tests and treatment for Indians. Furthermore, in March 2018, the Government of India, in association with the Directorate of General Health Services, introduced a new scheme known as “Nikshay Poshak Yojna” that included the provision of nutritional support for patients suffering with TB in India. Similarly, another scheme known as Direct Benefit Transfer (DBT) has been introduced for patients suffering from TB. This policy involves direct transfer of cash to the victim’s account intended for TB diagnostic tests, treatments, and medication costs.
Furthermore, western countries such as the US, the UK, and Canada are giving significant importance in combating TB by undertaking various funding programs. The US government is the largest donor of the Global Fund to fight AIDS, tuberculosis, and malaria. The US funding for global TB efforts was reported to be US$ 321 million in 2020. Thus, the financial and medical assistance from the governments for fighting the disease and promoting the diagnosis of TB is providing a lucrative scenario for the growth of the market.
Latent TB Detection Market– by Test
- Tuberculin Skin Test (TST)
- Interferon Gamma Released Assay (IGRA)
Latent TB Detection Market– by End User
- Diagnostic Centers
Place an Order Now: https://www.theinsightpartners.com/buy/TIPRE00014239/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.
Contact Person: Sameer Joshi